Longer Looks: Crowdfunding Health Care; Why Humans Sleep; And Pseudoscience In Health
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
The independent source for health policy research, polling, and news.
30,581 - 30,600 of 112,451 Results
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from New Hampshire, Massachusetts, Tennessee, Florida, Texas and New Jersey.
An "eye-opening" study finds vast disparities in cost within just one state. But some say that the study shows only one piece of the complex puzzle behind rising health care costs in Minnesota and across the nation.
Where there was once a stigma for men to enter the female-dominated field of nursing, the changing economical and social landscape is changing that. “This narrative that men can’t provide care in the way that women can is part of that broad cultural narrative that misunderstands what nursing’s about,” said Adam White, a nursing student.
But a recent study found that, overall, infant mortality declined in recent years.
There are vast geological disparities when it comes to availability of organs for donation, but a recent lawsuit may change that. In other public health news: sugar, nursing homes, hospitals gowns, "raw water," dental health and meat allergies.
Participants in the court, which recognizes failure as part of the process and not something that should be punished, are required to appear daily before Judge Craig D. Hannah. Court systems around the country are watching the Buffalo, N.Y., initiative as a potential model. Media outlets report on news from the drug crisis out of California and Tennessee as well.
The Rhode Island lawsuit centers on a Medicaid program that helps elderly and disabled enrollees pay their Medicare premiums. Elsewhere, Republican Kansas Gov. Sam Brownback names a lawyer who helped fight to block Medicaid payments to Planned Parenthood to serve as the interim head of the state agency that oversees the program.
Medicare Advantage Disenrollment Period, which is open until Feb. 14, allows people enrolled in an Advantage plan for 2018 to switch to original Medicare. Meanwhile, in other Medicare news, the Centers for Medicare & Medicaid Services will start reviewing Advantage networks on three-year cycles.
Last month lawmakers were briefed by a psychiatrist on the signs that might indicate President Donald Trump is having mental health issues. The president's latest tweet on North Korea has done nothing to soothe those concerns.
Since insurers have had time to adjust to "negative factors" and policy changes, analysts predict that marketplaces will remain stable for a year and maybe beyond.
The biggest generic threat to Allergan is to its eye treatment drug Restasis. The company has taken various steps to shield Restasis from competition, notably selling its patents to an Indian tribe in New York state to avoid a U.S. Patent and Trademark Office hearing on the validity of the drug’s patents.
In a novel arrangement, drugmaker Spark Therapeutics will offer discounts based on whether or not the drug, Luxturna, works initially and remains effective.
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from news outlets around the country.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from North Carolina, California, Illinois, Florida, Missouri, Colorado, Ohio and Connecticut.
Next year, people who qualify for Medicaid and have a body mass index of 30 or higher will have access to at least 12 visits a year with a healthcare professional. News outlets also report on Medicaid developments in Colorado, California, Maryland and Illinois.
Under the proposed changes, risk scores used to set payments would take into account certain diagnoses of mental health disorders, substance abuse disorders and chronic kidney disease. Meanwhile, the Department of Health and Human Services has finalized a rule that offers providers and payers more flexibility to share substance abuse patients' data.
© 2026 KFF